Related Experiment Videos
Endothelial Progenitor Cells' Classification and Application in Neurological Diseases
Jing-Jing Yuan1,2, Jing Yang1, Shi-Lei Sun1
11Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, 1 Jian-she East Road, Zhengzhou, 450000 Henan China.
Tissue Engineering and Regenerative Medicine
|January 4, 2019
Summary
Endothelial progenitor cells (EPCs) show therapeutic potential for ischemic stroke. Endothelial outgrowth cells (EOCs) exhibit superior characteristics for these therapies, warranting further research into EPC mechanisms for neurological diseases.
Area of Science:
- Regenerative Medicine
- Cell Biology
- Neurology
Background:
- Endothelial progenitor cells (EPCs) are investigated for treating ischemic stroke.
- The distinction between early EPCs and endothelial outgrowth cells (EOCs) remains unclear.
- Understanding these differences is crucial for optimizing EPC applications in ischemic diseases.
Purpose of the Study:
- To clarify the properties and functions of early EPCs and EOCs.
- To compare their suitability for therapeutic applications in neurological diseases.
- To review current research on EPCs and EOCs in the context of ischemic conditions.
Main Methods:
- Review of literature on cellular origin, isolation, and culture of EPCs and EOCs.
- Analysis of surface markers for differentiating early EPCs and EOCs.
- Examination of preclinical and clinical studies on EPC applications in neurological diseases.
Main Results:
- EOCs demonstrate characteristics of true endothelial progenitors.
- EOCs possess significant advantages over early EPCs for therapeutic use in ischemic diseases.
- Ongoing studies explore various preclinical and clinical applications of EPCs in neurological disorders.
Conclusions:
- EOCs are identified as having superior potential for cell-based therapies in ischemic diseases.
- Further research is necessary to elucidate the specific characteristics and mechanisms of EPCs in neurological diseases.
- Clarifying EPC and EOC properties will enhance their therapeutic utility.